CI Private Wealth »

SPDR S&P Pharmaceuticals shares owned by CI Private Wealth

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by CI Private Wealth from 13F filings

Historical chart of CI Private Wealth investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by CI Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by CI Private Wealth

Quarter filed Position value Share count Share price at filing
2026-06-30 $225k 3.4k 66.27
2025-06-30 $294k 7.3k 40.58

More positions owned by CI Private Wealth

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Costco Wholesale Corporation (COST)

View all positions for CI Private Wealth

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
CWM
Wells Fargo & Company
Kingsview Wealth Management
Morgan Stanley
Envestnet Asset Management
First Citizens Bank & Trust
Envestnet Portfolio Solutions
LPL Financial
Branch Banking & Trust Company
Measured Wealth Private Client Group
Private Advisor
UBS Group
Susquehanna International
Citigroup

View all funds holding SPDR S&P Pharmaceuticals